← FDA DRUG APPROVALS

FDA ANDA · ANDA214302

SELEXIPAG

Sponsor: ZYDUS LIFESCIENCES

APPLICATION
ANDA214302
TYPE
ANDA
ORIGINAL APPROVAL
2022-12-21
LATEST ACTION
2022-12-21
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

SELEXIPAGDiscontinued
SELEXIPAG 1.4MG · TABLET · ORAL
SELEXIPAGDiscontinued
SELEXIPAG 1MG · TABLET · ORAL
SELEXIPAGDiscontinued
SELEXIPAG 0.6MG · TABLET · ORAL
SELEXIPAGDiscontinued
SELEXIPAG 0.2MG · TABLET · ORAL
SELEXIPAGDiscontinued
SELEXIPAG 1.6MG · TABLET · ORAL
SELEXIPAGDiscontinued
SELEXIPAG 1.2MG · TABLET · ORAL
SELEXIPAGDiscontinued
SELEXIPAG 0.8MG · TABLET · ORAL
SELEXIPAGDiscontinued
SELEXIPAG 0.4MG · TABLET · ORAL

Approval history

2022-12-21UNKNOWN · Original · standardLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →